Company Quick10K Filing
Biotime
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.92 150 $138
10-Q 2019-09-30 Quarter: 2019-09-30
10-Q 2019-06-30 Quarter: 2019-06-30
10-Q 2019-03-31 Quarter: 2019-03-31
10-K 2018-12-31 Annual: 2018-12-31
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-Q 2017-06-30 Quarter: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-K 2016-12-31 Annual: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-Q 2016-06-30 Quarter: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-K 2015-12-31 Annual: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-Q 2015-06-30 Quarter: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-K 2014-12-31 Annual: 2014-12-31
10-Q 2014-09-30 Quarter: 2014-09-30
10-Q 2014-06-30 Quarter: 2014-06-30
10-Q 2014-03-31 Quarter: 2014-03-31
10-K 2013-12-31 Annual: 2013-12-31
8-K 2019-11-12 Earnings, Exhibits
8-K 2019-10-14 Other Events, Exhibits
8-K 2019-09-19 Other Events, Exhibits
8-K 2019-08-09 Amend Bylaw, Other Events, Exhibits
8-K 2019-08-08 Earnings, Exhibits
8-K 2019-07-30 Officers, Shareholder Vote
8-K 2019-07-02 Officers
8-K 2019-05-09 Earnings, Exhibits
8-K 2019-05-09 Other Events
8-K 2019-05-02 Other Events, Exhibits
8-K 2019-04-26 Other Events, Exhibits
8-K 2019-04-23 Other Events, Exhibits
8-K 2019-03-14 Earnings, Exhibits
8-K 2019-03-14 Other Events
8-K 2019-03-08 M&A, Officers, Shareholder Vote, Exhibits
8-K 2019-03-01 Other Events
8-K 2019-02-19 Officers
8-K 2019-02-14 Other Events, Exhibits
8-K 2019-01-03 Officers
8-K 2018-12-17 Officers
8-K 2018-11-28 M&A, Exhibits
8-K 2018-11-08 Earnings, Exhibits
8-K 2018-11-07 Enter Agreement, Other Events, Exhibits
8-K 2018-10-04 Officers
8-K 2018-09-17 Officers, Exhibits
8-K 2018-08-30 Enter Agreement, M&A, Exhibits
8-K 2018-08-02 Earnings, Exhibits
8-K 2018-08-01 Enter Agreement, Exhibits
8-K 2018-05-24 Officers
8-K 2018-05-01 Shareholder Vote, Other Events
8-K 2018-03-20 Officers
8-K 2018-03-15 Officers
8-K 2018-02-21 Officers, Exhibits

Biotime Financials

-

BTX Metrics, Comps, Filings


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Quarter)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
LogicBio Therapeutics (LOGC) 294,144 68,030 4,619 0 0 -35,361 -35,124 268,542
ADMA Biologics (ADMA) 221,849 143,274 96,368 18,376 -22,067 -57,386 -47,412 220,733
Acorda Therapeutics (ACOR) 351,396 1,197,462 652,625 306,156 241,095 -79,407 5,827 203,300
Hemispherx Biopharma (HEB) 9,724 13,808 7,260 307 0 -10,082 -13,198 11,183
Atyr Pharma (LIFE) 1,342 48,762 18,536 94 0 -25,421 -24,727 -748
Biotime (BTX) 158,622 151,691 19,932 982 3,185 31,051 32,100 141,922
Jounce Therapeutics (JNCE) 142,795 190,604 100,540 63,055 0 -29,047 -29,023 103,531
Nantkwest (NK) 103,223 175,696 24,427 60 0 -75,542 -65,376 85,515
Liquidia Technologies (LQDA) 157,119 64,711 32,618 8,810 8,003 -39,027 -37,689 120,998
PolarityTE (PTE) 144,755 84,955 14,589 4,338 2,468 -88,098 -85,864 99,642
Gamida Cell (GMDA) 244,571 65,164 0 0 0 0 241,282
Allena Pharmaceuticals (ALNA) 97,603 53,582 15,909 0 0 -41,813 -41,813 49,080
Fennec Pharmaceuticals (FENC) 74,013 17,829 1,353 0 0 -13,089 -13,089 56,538
Brainstorm Cell Therapeutics (BCLI) 86,400 8,864 13,380 0 0 -18,486 -18,486 85,274
Neon Therapeutics (NTGN) 131,857 79,682 17,476 0 0 -84,471 -82,864 70,857
Champions Oncology (CSBR) 91,794 13,362 11,634 0 0 -996 -207 89,592
Curis (CRIS) 60,761 48,240 68,509 2,755 0 -30,261 -27,380 25,461
Idera Pharmaceuticals (IDRA) 77,545 54,332 6,597 0 0 -45,274 -45,002 25,145
VBI Vaccines (VBIV) 107,533 114,649 38,396 1,259 -2,884 -62,396 -59,253 91,814

Balance Sheet ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash22,21216,48812,6607,8304,3509,89614,3066,7175,4956,63815,7227,41629,48725,83031,46529,37842,22927,13227,70230,45122,08823,81614,55016,66238,20031,40029,20032,20030,70027,10016,700
Accounts Receivable57489140447842046157660061366254960654566475434413951
Inventory51555557555265611792372582542662992972601
PP&E1,3481,3852,0082,0632,0992,6132,8514,0944,4324,6454,9434,9524,8714,9295,6526,7817,5398,9324,0624,7265,5294,9925,2405,4235,5335,3665,0145,1175,8358,9188,720
Assets45,83038,97838,38132,87029,74935,29739,89430,85457,73057,95065,98555,65574,90169,70379,61076,85994,66080,114104,327147,574142,572205,216193,353221,867173,241110,395112,251176,077101,660183,715151,691
Accounts Payable8917091,1681,4611,6882,2023,8882,5271,8802,4232,2972,7072,6611,9342,7984,5461,7581,6871,5931,0647525089387031,1817172,3591,3792,778
Long-Term Debt
Liabilities4,3723,1474,0873,6595,4545,3155,3765,48515,46712,58619,40116,70012,17812,19214,65915,92518,21334,19110,27511,33312,06415,51915,16812,8808,9787,9407,5006,5199,41422,47919,932
Stockholders' Equity28,64624,19923,17716,9409,58515,84520,91612,94014,80119,24317,91210,98136,45626,25016,97913,04326,89110,85285,743119,391117,928187,372176,125198,286162,64199,968100,981171,12793,840162,844133,387
Income Statement ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue6321,0341,0041,0666141,2167141,6701,0671,4591,1921,8781,2642,0092,3061,3112,0731,2661,4991,1033903811,6889457012,547982
Cost of Revenue841701831812072221322512312232642604321502259558-205755254109106355268140
Gross Profit9508344321,0365071,6709351,2839611,6551,0001,7491,8741,3111,8481,1711,4411,1033333761,6369455922,441947706860672
R&D4,1794,6154,5455,3955,5806,4419,2208,40511,0288,83611,2659,3249,05911,43312,78813,7348,9386,4227,0136,4946,3436,5624,6975,9356,3584,8823,7804,9615,314
SG&A
Tax-1,349-1,513-2,3130
Net Income-4,973-5,457-4,958-6,037-7,719-7,550-9,003-19,612-8,099-8,606-8,219-10,568-10,167-9,691-13,626-14,747-17,11224,54931,199-4,94549,2886,43814,321-71,934-63,548-4,21566,725-44,95239,310-30,032
Cash Flow ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating-5,717-3,958-5,009-7,022-7,444-6,416-8,627-10,357-7,681-5,675-10,338-7,400-7,332-5,812-9,314-9,667
Cash Investing-117260-52-551-239-1,218-1,659-5284,842-5832,211-41-1389,7842,946-194
Cash Financing01527213,11312,024-09,12612,1284,99226,3796334,90214594606-63